Home > Insider Trading > Filing (0001736297-25-000040)

Filing Details

Accession Number:: 0001736297-25-000040
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-05-20 21:13:12
Reporting Period:: 2025-05-16

Filing Date:: 2025-05-20
Accepted Time:: 2025-05-20 21:13:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1736297	Astera Labs Inc.	ALAB	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1399546	Truett Michael Tate	C/O Astera Labs, Inc. 2901 Tasman Drive, Suite 205 Santa Clara CA 95054	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2025-05-16	881	$92.16	243,361	No	4	S	Direct
Common Stock	Disposition	2025-05-16	4,247	$90.67	239,114	No	4	S	Direct
Common Stock	Disposition	2025-05-16	3,979	$90.33	235,135	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,118,996	Indirect	By Tate Trust

Footnotes

Represents shares of the Issuer's Common Stock required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stockunits previously granted to the Reporting Person. Such sales were automatic and mandated by an election of the Issuer made in advance of the vesting event to require the satisfaction of tax withholding obligations to be funded by a "sell to cover", and does not represent a discretionary trade by the Reporting Person.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.7300 to $92.5550, inclusive. The Reporting Person undertakes toprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate pricewithin the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.4250 to $91.4200, inclusive. The Reporting Person undertakes toprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate pricewithin the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $90.2400 to $90.4200, inclusive. The Reporting Person undertakes toprovide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separateprice within the range set forth in this footnote.
These shares are owned directly by the Tate 1997 Living Trust Dated April 24, 1997 (the "Tate Trust"), of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.